Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

294 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nanobody-targeted photodynamic therapy induces significant tumor regression of trastuzumab-resistant HER2-positive breast cancer, after a single treatment session.
Deken MM, Kijanka MM, Beltrán Hernández I, Slooter MD, de Bruijn HS, van Diest PJ, van Bergen En Henegouwen PMP, Lowik CWGM, Robinson DJ, Vahrmeijer AL, Oliveira S. Deken MM, et al. Among authors: lowik cwgm. J Control Release. 2020 Jul 10;323:269-281. doi: 10.1016/j.jconrel.2020.04.030. Epub 2020 Apr 21. J Control Release. 2020. PMID: 32330574 Free PMC article.
EGFR targeted nanobody-photosensitizer conjugates for photodynamic therapy in a pre-clinical model of head and neck cancer.
van Driel PBAA, Boonstra MC, Slooter MD, Heukers R, Stammes MA, Snoeks TJA, de Bruijn HS, van Diest PJ, Vahrmeijer AL, van Bergen En Henegouwen PMP, van de Velde CJH, Löwik CWGM, Robinson DJ, Oliveira S. van Driel PBAA, et al. Among authors: lowik cwgm. J Control Release. 2016 May 10;229:93-105. doi: 10.1016/j.jconrel.2016.03.014. Epub 2016 Mar 15. J Control Release. 2016. PMID: 26988602 Free PMC article.
Acute cellular and vascular responses to photodynamic therapy using EGFR-targeted nanobody-photosensitizer conjugates studied with intravital optical imaging and magnetic resonance imaging.
de Bruijn HS, Mashayekhi V, Schreurs TJL, van Driel PBAA, Strijkers GJ, van Diest PJ, Lowik CWGM, Seynhaeve ALB, Hagen TLMT, Prompers JJ, Henegouwen PMPVBE, Robinson DJ, Oliveira S. de Bruijn HS, et al. Among authors: lowik cwgm. Theranostics. 2020 Jan 20;10(5):2436-2452. doi: 10.7150/thno.37949. eCollection 2020. Theranostics. 2020. PMID: 32089747 Free PMC article.
Intraoperative fluorescence delineation of head and neck cancer with a fluorescent anti-epidermal growth factor receptor nanobody.
van Driel PB, van der Vorst JR, Verbeek FP, Oliveira S, Snoeks TJ, Keereweer S, Chan B, Boonstra MC, Frangioni JV, van Bergen en Henegouwen PM, Vahrmeijer AL, Lowik CW. van Driel PB, et al. Int J Cancer. 2014 Jun 1;134(11):2663-73. doi: 10.1002/ijc.28601. Epub 2013 Dec 12. Int J Cancer. 2014. PMID: 24222574 Free PMC article.
Translational optical imaging in diagnosis and treatment of cancer.
Keereweer S, Hutteman M, Kerrebijn JD, van de Velde CJ, Vahrmeijer AL, Löwik CW. Keereweer S, et al. Curr Pharm Biotechnol. 2012 Mar;13(4):498-503. doi: 10.2174/138920112799436294. Curr Pharm Biotechnol. 2012. PMID: 22214505 Review.
Shifting focus in optical image-guided cancer therapy.
Keereweer S, Van Driel PB, Robinson DJ, Lowik CW. Keereweer S, et al. Mol Imaging Biol. 2014 Feb;16(1):1-9. doi: 10.1007/s11307-013-0688-x. Mol Imaging Biol. 2014. PMID: 24037176 Review.
294 results